Are we done with dose-intense temozolomide in recurrent glioblastoma?

Neuro Oncol. 2014 Sep;16(9):1161-3. doi: 10.1093/neuonc/nou157. Epub 2014 Jul 25.

Authors

Martin J van den Bent¹, Walter Taal¹

Affiliation

¹ Dr Daniel den Hoed Cancer Center Rotterdam, The Netherlands (M.J.v.d.B.); Dept Neuro-Oncology/Neurology Erasmus MC Cancer Institute, Rotterdam, The Netherlands (M.J.v.d.B., W.T.).

No abstract available

Publication types

Editorial
Kommentar

MeSH terms

Antineoplastic Agents, Alkylating / therapeutic use*
Brain Neoplasms / drug therapy*
Dacarbazine / analogs & derivatives*
Female
Glioma / drug therapy*
Humans
Male

Substances

Antineoplastic Agents, Alkylating
Dacarbazine